Stock 300404 BOJI MEDICAL TECHNOLOGY CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Boji Medical Technology Co.,Ltd.

Equities

300404

CNE100001Y00

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-21 pm EDT 		5-day change 1st Jan Change
7.86 CNY -0.51% Intraday chart for Boji Medical Technology Co.,Ltd. +0.26% -12.18%
Apr. 24 Boji Medical Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 08 Boji Medical Technology Inks 70 Million Yuan Technical Services Deal With Ruianbo Pharmaceutical Technology MT

Business Summary

Boji Medical Technology Co Ltd is a China-based company that provides Contract Research Organization (CRO) services. The Company mainly provides one-stop CRO services for the development and production of new drugs and medical devices for domestic and foreign pharmaceutical companies and other research institutions. The Company's CRO services include pre-clinical research services, clinical research services, other consulting services, pharmaceutical Contract Development Manufacture Organization (CDMO) services, pre-clinical independent research and development services, and technology achievement transformation services. The Company mainly conducts its businesses in the domestic market.

Number of employees: 1,091

Sales per Business

CNY in Million2022Weight2023Weight Delta
Clinical Research Services
74.6 %
277 65.4 % 415 74.6 % +49.58%
Pre-clinical Research Services
14.1 %
74 17.4 % 78 14.1 % +6.19%
Other Consultancy Services
8.7 %
41 9.6 % 49 8.7 % +19.06%
Other Business
2.6 %
13 3.0 % 14 2.6 % +12.81%
Pre-clinical Independent Research and Development
0.0 %
11 2.7 % 0 0.0 % -97.78%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
99.4 %
408 99.3 % 553 99.4 % +35.42%
Hong Kong, Macau and Taiwan
0.3 %
2 0.5 % 2 0.3 % -7.02%
Abroad
0.2 %
1 0.2 % 1 0.2 % +35.03%

Managers

Managers TitleAgeSince
Ting Cun Wang CEO
 Chief Executive Officer 59 11-06-10
Xiu Qing Ou DFI
 Director of Finance/CFO 42 03-11-30
Bo Tan BRD
 Director/Board Member 42 05-09-30
Quan Zhu BRD
 Director/Board Member 52 08-01-31
Shao Hua Chen IRC
 Investor Relations Contact - -
Fang Qun Wei SEC
 Corporate Secretary 39 11-05-31
Yu Ping Han PRN
 Corporate Officer/Principal 51 08-10-31

Members of the board

Members of the board TitleAgeSince
Ting Cun Wang CEO
 Chief Executive Officer 59 11-06-10
Yu Ping Han PRN
 Corporate Officer/Principal 51 08-10-31
Bo Tan BRD
 Director/Board Member 42 05-09-30
Ke Jian Zhang BRD
 Director/Board Member 68 20-07-27
Kang Xie BRD
 Director/Board Member 61 22-05-16
Qing Chen BRD
 Director/Board Member 70 20-07-27
Jing Chun Liu CHM
 Chairman - 23-08-02
Fang Wang BRD
 Director/Board Member 38 20-07-27
Hua Yi Li BRD
 Director/Board Member - 23-08-01
Peidan Xian BRD
 Director/Board Member - 23-08-01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 383,007,238 225,517,063 ( 58.88 %) 800,000 ( 0.2089 %) 58.88 %

Shareholders

NameEquities%Valuation
China Southern Asset Management Co., Ltd.
5.000 %
7,504,300 5.000 % 8 M ¥
Golden Eagle Asset Management Co., Ltd.
2.299 %
3,450,380 2.299 % 4 M ¥
Changsheng Fund Management Co., Ltd.
1.313 %
1,970,000 1.313 % 2 M ¥
GF Fund Management Co., Ltd.
0.4330 %
649,800 0.4330 % 693 636 ¥
Zhong Ou Asset Management Co., Ltd
0.3563 %
534,700 0.3563 % 570 771 ¥
Golden Trust Sinopac Fund Management Co., Ltd.
0.3332 %
500,000 0.3332 % 533 730 ¥
Hongde Fund Management Co., Ltd.
0.0894 %
134,200 0.0894 % 143 253 ¥
CITIC-Prudential Fund Management Co., Ltd.
0.0666 %
100,000 0.0666 % 106 746 ¥
Fullgoal Fund Management Co., Ltd.
0.0651 %
97,700 0.0651 % 104 291 ¥
Citic Securities Co., Ltd. (Invt Port)
0.0507 %
76,100 0.0507 % 81 234 ¥

Company contact information

Boji Medical Technology Co., Ltd.

7/F, Block A, Vanke Cloud Plaza 1933 Huaguan Road

510640, Guangzhou

+

http://www.gzboji.com
address Boji Medical Technology Co.,Ltd.(300404)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Sales per region

Ratings for Boji Medical Technology Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
7.86 CNY
Average target price
11.74 CNY
Spread / Average Target
+49.36%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
BOJI MEDICAL TECHNOLOGY CO.,LTD. Stock Boji Medical Technology Co.,Ltd.
-12.18% 412M
MODERNA, INC. Stock Moderna, Inc.
+64.23% 62.59B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-2.31% 41.18B
LONZA GROUP AG Stock Lonza Group AG
+45.55% 40.29B
CELLTRION, INC. Stock Celltrion, Inc.
-8.29% 27.9B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.97% 26.21B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.16% 19.09B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+7.54% 13.08B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+25.72% 12.26B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.17% 12.05B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. 300404 Stock
  4. Company Boji Medical Technology Co.,Ltd.